A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC
Asan Medical Center
Asan Medical Center
Eli Lilly and Company
Hoffmann-La Roche
AstraZeneca
AstraZeneca
Memorial Sloan Kettering Cancer Center
Imugene Limited
Eurofarma Laboratorios S.A.
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
European Organisation for Research and Treatment of Cancer - EORTC
Merck Sharp & Dohme LLC
HonorHealth Research Institute
Medical College of Wisconsin
NuCana plc
Chonnam National University Hospital
University Health Network, Toronto
Memorial Sloan Kettering Cancer Center
Merck KGaA, Darmstadt, Germany
Boehringer Ingelheim
Genentech, Inc.
University of Miami
Eurofarma Laboratorios S.A.
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)